Peer Group Amgen Aktie
Name | Kurs | +/-% |
---|
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | Kaufen |
Orderbuch | Realtime Stuttgart | Fundamentalanalyse | Rating | Insidertrades | Fonds | im Forum |
Historisch | Realtime Push | myNews | Anleihen |
Rating | Baa1 | Rating TypBank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
Letzte Aktion | New | Moody's Büro in | - |
Emittent | Anzahl Anleihen | Ratings |
---|---|---|
Amgen Inc. | 31 | Baa1 |
Aktie | Rating |
---|---|
Bayer | Baa2 |
Biogen Inc | Baa2 |
Gilead Sciences Inc. | A3 |
Sanofi S.A. | A1 |
Aktie | Rating |
---|---|
General Electric Co. | A1 |
Pfizer Inc. | A1 |
Sanofi S.A. | A1 |
Celgene Corp. | A3 |
Gilead Sciences Inc. | A3 |
Merck KGaA | A3 |
Johnson & Johnson | Aaa |
Bayer | Baa2 |
Biogen Inc | Baa2 |
Regeneron Pharmaceuticals Inc. | Baa3 |
ETF-Sparplan